In a diagnostic laboratory performing numerous blot assays per day, it may turn into an ordeal to accurately and carefully place every strip of a line blot with a tweezer into the incubation tray. And during the incubation it is essential to ensure that the strips are always covered with sufficient liquid and do not […]
In its recent epidemiological bulletin (no. 15) the German Robert Koch Institute reports about exceedingly high numbers of hantavirus infections in Germany. In total, 1,713 cases had been registered in 2017 – in the previous year, there were only 298. Indeed, the number of infections fluctuates considerably from year to year. Also 2007, 2010 and 2012 were
Previous year, EUROIMMUN launched the Anti-Zika Virus ELISA IgA. It had turned out that specific anti-Zika virus IgA antibodies against the non-structural protein 1 (NS1) could serve as alternative indicators of acute infection phase if specific IgM antibodies were not detectable. Particularly when patients, who already have had a first contact with a flavivirus (infection
Measles and mumps, two forgotten diseases, reveal an unfortunate comeback. In a free webinar on February 15th, Oliver Sendscheid, PhD, Scientific Director at EUROIMMUN US, and Rolando Pajon, PhD, Lead Scientist for Vaccine and Novel Immunotherapeutic Laboratory Solutions at COVANCE CLS addressed the current epidemiologic status of measles and mumps, challenges and solutions in serological testing,
Measles and mumps, two forgotten diseases, reveal an unfortunate comeback. In a free webinar, Oliver Sendscheid, PhD, Scientific Director at EUROIMMUN US, and Rolando Pajon, PhD, Lead Scientist for Vaccine and Novel Immunotherapeutic Laboratory Solutions at COVANCE CLS address the current epidemiologic status of measles and mumps, challenges and solutions in serological testing, perspectives in vaccine
